GlassScriptPhysician profile
Leslie Delaney
NPI 1982715454
$2,530.75
in general payments reported to CMS, 2019-2025
18 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $376 · 2021: $493 · 2022: $381 · 2023: $275 · 2024: $215 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $622.62 | 2019-2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $348.90 | 2020-2025 | |
| Pfizer INC. | $297.32 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $282.94 | 2019-2022 | |
| Glaxosmithkline, LLC. | $212.28 | 2019-2025 | Pediarix, Bexsero |
| Ironshore Pharmaceuticals INC. | $208.51 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $186.71 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Corium, LLC | $134.66 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $54.54 | 2025 | Jornay Pm |
| Arbor Pharmaceuticals, INC. | $38.11 | 2019 | |
| Seqirus USA INC | $28.85 | 2024 | Flucelvax |
| Abbvie INC. | $24.78 | 2021 | |
| Supernus Pharmaceuticals, INC. | $21.14 | 2023 | Qelbree |
| Genentech USA, INC. | $18.11 | 2019 | |
| Allergan, INC. | $14.66 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $13.39 | 2020 | |
| Mission Pharmacal Company | $12.10 | 2019 | |
| Almirall LLC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Delaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.